Article Details

Buy Rating Affirmed for Taysha Gene Therapies Amid Anticipated Data and Strong Financial Position

Retrieved on: 2024-08-13 18:43:28

Tags for this article:

Click the tags to see associated articles and topics

Buy Rating Affirmed for Taysha Gene Therapies Amid Anticipated Data and Strong Financial Position. View article details on hiswai:

Excerpt

Analyst Yanan Zhu of Wells Fargo maintained a Buy rating on Taysha Gene Therapies (TSHA – Research Report), retaining the price target of ...

Article found on: markets.businessinsider.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up